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Abstract 27 
 28 
Purpose: To investigate neuropathological changes in the superior colliculus (SC) in 29 
chronic traumatic encephalopathy (CTE). 30 
 31 
Methods: The densities of the tau-immunoreactive neurofibrillary tangles (NFT), 32 
neuropil threads (NT), dot-like grains (DLG), astrocytic tangles (AT), and neuritic 33 
plaques (NP), together with abnormally enlarged neurons (EN), typical neurons (TN), 34 
vacuolation, and frequency of contacts with blood vessels were studied across the SC 35 
from pia mater to the periaqueductal gray (PAG) in eight CTE and six control cases. 36 
 37 
Results: Tau-immunoreactive pathology was absent in the SC of controls but present 38 
in varying degrees in all CTE cases, significant densities of NFT, NT, or DLG being 39 
present in three cases. No significant differences in overall density of the NFT, NT, 40 
DLG, EN, vacuoles, or contacts with blood vessels were observed in control and CTE 41 
cases, but CTE cases had significantly lower mean densities of neurons. The 42 
distribution of surviving neurons across the SC suggested greater neuronal loss in 43 
intermediate and lower laminae in CTE. Changes in density of the tau-44 
immunoreactive pathology across the laminae were variable but in six CTE cases, 45 
densities of NFT, NT, or DLG were significantly greater in intermediate and lower 46 
laminae. Pathological changes were not correlated with the distribution of blood 47 
vessels. 48 
  49 
Conclusions: The data suggest significant pathology affecting the SC in a proportion 50 
of CTE cases with a laminar distribution which could compromise motor function 51 
rather than sensory analysis.  52 
 53 
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Introduction 59 
 60 
Chronic traumatic encephalopathy (CTE) is a neurodegenerative disorder resulting 61 
from brain injury often accompanied by concussion.1,2 It has been recorded in 62 
association with a variety of contact sports including boxing, American football, 63 
hockey, and wrestling3 and also in military veterans exposed to blast shock waves 64 
from explosive devices.4-7 Clinical symptoms of CTE include impairment of memory 65 
and executive function, behavioral change, and the presence of motor symptoms.8  66 
 67 
Currently, CTE can only be diagnosed definitively using neuropathological criteria, 68 
cases exhibiting reduced gray matter volume in several brain regions, most 69 
prominently in frontal and anterior temporal lobes and associated with enlargement of 70 
the lateral and third ventricles.5,9,10 Cases of CTE exhibit a complex histopathology in 71 
which the major feature is the formation of cellular aggregates in neurons and glia of 72 
the microtubule-associated protein (MAP) tau.5,11 The neuronal pathology includes 73 
deposition of abnormal tau in the form of abnormal filaments, viz. neurofibrillary 74 
tangles (NFT) in frontal cortex,11 temporal lobe, limbic system, and the striato-nigral 75 
system.5 In addition, the pathology includes neuropil threads (NT) which may 76 
represent degenerating neurites and dot-like grains (DLG) which may represent 77 
synaptic structures. Abnormal aggregates of phosphorylated tau (ptau) may also occur 78 
in thorned astrocytes (AT).8,9,10,11 The isoform profile and phosphorylation state of tau 79 
in CTE is similar to that of Alzheimer’s disease (AD)12 in that both three-repeat (3R) 80 
and four-repeat (4R) tau are present in equal ratios. Co-morbid AD neuropathologic 81 
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change (ADNC), viz., deposits of the protein beta-amyloid (A) in association with 82 
neuritic degeneration termed neuritic plaques (NP).13,14 In addition, abnormally 83 
enlarged neurons (EN), and vacuolation have been recorded in CTE as in other 84 
tauopathies.15-17 Spatial correlations between tau pathology and blood vessels have 85 
also been reported suggesting dysfunction of the blood brain barrier (BBB) could be a 86 
factor in CTE.5,9 87 
 88 
There is little available information on possible eye dysfunction relating directly to 89 
CTE. However, moderate to severe brain injury is associated with dysfunction of 90 
saccades and pursuits18 and disconjugate eye movements especially affecting 91 
horizontal movement, have been recorded in 80% of individuals with concussion or 92 
blast injury.19 The superior colliculus (SC) is a region of mid-brain involved in 93 
directing a behavioral response, via eye movements, towards a specific point or 94 
object.20-22 It has a laminar structure consisting of seven layers (Fig 1), with 95 
alternating fiber-rich and cell-rich bands, the superficial layers (laminae I/II/III) being 96 
sensory in function and receiving input from the eyes and other sensory systems, 97 
while the deeper layers (laminae VI/VII) are motor-related and involved in the control 98 
of eye movements. The intermediate laminae (IV/V) are involved in both sensory and 99 
motor function. Tau-immunoreactive pathology has been observed in the SC in 100 
various neurodegenerative disorders including AD23,24, corticobasal degeneration 101 
(CBD)25, and progressive supranuclear palsy (PSP)24 and in transgenic animal models 102 
of disease such as the ‘tau-filament forming mice’26 and in a triple mutation mouse 103 
model.27 In addition, pathology in the SC in PSP results in ‘slow vertical and 104 
horizontal saccades’ or sequences of small amplitude saccades with preserved 105 
velocity.28  Neuronal loss in the SC in Parkinson’s disease (PD) also results in loss of 106 
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modulation which disturbs the balance between triggering and sustaining the input 107 
necessary for normal single-step saccades.29 Hence, if there is tau pathology in the SC 108 
in CTE, it may give rise to possible eye movement dysfunction in the disorder. Hence, 109 
to test this hypothesis the densities of the tau-immunoreactive pathological changes, 110 
viz. NFT, NT, DLG, AT, NP together with EN, typical neurons (TP), vacuolation, and 111 
frequency of contacts with visible blood vessel profiles were studied across the SC in 112 
eight neuropathologically verified CTE cases and six controls. The study had the 113 
following objectives: (1) to determine whether there were quantitative differences in 114 
the pathology of the SC in neuropathologically diagnosed CTE cases and controls, (2) 115 
to determine whether the pathology was lamina specific, (3) to determine whether the 116 
pathological changes were correlated with the distribution of blood vessels, and (4) to 117 
consider how SC pathology might affect eye movements in CTE. 118 
 119 
Materials and methods 120 
 121 
Cases  122 
 123 
Preserved samples of brain obtained at post-mortem of the CTE cases (N = 8, mean 124 
age 71 years, Range 61 – 82 years, SD = 6.94) (Table 1) were obtained from the 125 
Veterans Affairs – Boston University – Concussion Legacy Foundation ()VA-BU-126 
CLF) Brain Bank.  Control cases (N = 6, mean age 74 years, Range 64 – 83 years, SD 127 
= 8.21), with no neurological or psychiatric histories, with no recent evidence of brain 128 
trauma in medical records, and without ADNC (NIA-AA A0, B0)30, were obtained 129 
from either the University of Birmingham Medical School or the Medical Research 130 
Council Neurodegenerative Disease Brain Bank, Department of Neuropathology, 131 
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Institute of Psychiatry, King's College London, UK. With the exception of one case, a 132 
boxer for 26 years (Case C), subjects with CTE had played American football with 133 
career durations ranging from 11-24 years. All CTE patients subjects had suffered at 134 
least one symptomatic concussion and multiple subconcussion episodes of trauma 135 
over the course of their careers. No eye movement or eye tracking tests were carried 136 
out on any subject during life. Cases were pathologically diagnosed with CTE 137 
according to NINDS criteria published by McKee et al.10: (1) foci of perivascular 138 
NFT, TA, and DLG irregularly distributed in cortex with a predilection for the sulcal 139 
depths, (2) NFT in superficial laminae II/III especially in temporal cortex, and (3) 140 
clusters of subpial AT in the cortex were present as an additional finding.  141 
 142 
Histological methods  143 
 144 
These studies were approved by the local Institute Review Board of Boston 145 
University and were carried out according to the 1995 Declaration of Helsinki (as 146 
modified in Edinburgh, 2000). After death, the next-of-kin provided written consent 147 
for brain removal and retention for research studies. Brains were fixed in 10% neutral 148 
buffered formalin for at least two weeks, paraffin-embedded, and sections cut at 6 149 
m. A section of the mid-brain was taken from each at the level of the third cranial 150 
nerve to study the SC. Sections were stained with luxol fast blue in combination with 151 
hematoxylin and eosin (LHE). In addition, immunohistochemistry was performed 152 
using an antibody against phosphorylated tau (AT8, Pierce Endogen, Rockford, IL, 153 
USA; 1:2000). Due to the rarity of brain material from neuropathologically verified 154 
CTE cases, all microscope slides were scanned and provided as ‘virtual slides’ using 155 
Aperio Image-Scope Software (Leica Biosystems Inc. Buffalo Grove, IL, USA).  156 
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 157 
Morphometric methods 158 
 159 
The densities of the NFT, NT, DLG, AT, and NT together with EN, TN, vacuolation, 160 
and frequency of contacts with visible blood vessels was studied across the SC from 161 
pia mater to the periaqueductal gray (PAG). Two traverses were located at random 162 
normal to the laminar structure of the SC.31 Random points were used for sampling 163 
rather than fixed locations to avoid sample bias attributable to pathology in the SC 164 
varying parallel to the pia mater. In all cases, 250 x 50 µm contiguous sample fields 165 
were superimposed over the image using either the draw or rectangle options. The 166 
sample fields were located along each traverse from the pia mater to the edge of the 167 
PAG. All histological features, with the exception of the blood vessel profiles, were 168 
counted within each sample field. NFT were present in the cytoplasm of larger cells 169 
with a distinct region of haematoxylin-positive cytoplasm (Fig 2) while AT were 170 
associated with larger, pale nuclei. NT were thread-like structures some of which 171 
were serpiginous, while small circular structures were identified as GR. Neurons with 172 
an abnormally enlarged perikaryon, a nucleus displaced to the periphery of the cell, 173 
and a cell diameter at least three times the nucleus diameter was counted as an EN.32 174 
TN were identified as cells containing at least some stained cytoplasm in combination 175 
with larger shape and non-spherical outline.33 Additional structures can be identified 176 
in the sections including oligodendrocytes (small dark circular nuclei), astrocytes 177 
(larger light circular nuclei), and blood vessel profiles. The number of discrete 178 
vacuoles present in the neuropil greater than 5 m in diameter, was also recorded.34,35 179 
To quantify blood vessel profiles in a sample field, a line was drawn across the long 180 
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dimension of the field at a random location and the number of contacts between the 181 
line and visible blood vessel profiles recorded. 182 
 183 
Data analysis 184 
 185 
Data analyses were carried out using STATISTICA software (Statsoft Inc., Tulsa, 186 
OK, 74104, USA). First, comparison of overall mean densities of a histological 187 
feature between CTE case and controls was made using ‘t’ tests. Where no pathology 188 
was observed in controls, mean densities in CTE were compared to zero using a one-189 
sample ‘t’ test.36 Second, the degree of degeneration present in the CTE cases made 190 
identification of the seven layers of the SC difficult. In addition, the pathology 191 
exhibited complex patterns of distribution across the SC rather than being confined to 192 
specific laminae. Hence, variations in density across the SC were analyzed using a 193 
polynomial curve-fitting procedure.36,37 For each SC, polynomials were fitted 194 
successively to the data. Hence, quadratic curves are parabolic, cubic curves are ‘S’ 195 
shaped, and quartic curves often appear as ‘double-peaked’ or ‘bimodal’. With each 196 
fitted polynomial, the correlation coefficients (Pearson’s ‘r’), regression coefficients, 197 
standard errors (SE), values of ‘t’, and the residual mean square were obtained.43At 198 
each stage, the reduction in the sums of squares (SS) was tested for significance. The 199 
analysis was continued until either a non-significant value of F was obtained or there 200 
was little gain in the explained variance. To describe these distributions, the SC was 201 
divided into three zones: (1) an upper zone corresponding approximately to laminae I-202 
III, (2) an intermediate zone corresponding to laminae IV and V, and (3) a lower zone 203 
corresponding to laminae VI and VII. Third, to determine whether densities of 204 
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histological features were spatially correlated with each other, and with blood vessels, 205 
correlations were tested using Pearson's correlation coefficient (‘r’).38 206 
 207 
Results 208 
 209 
The abundance of tau pathology in each of the eight CTE cases and a control cases are 210 
shown in Fig 3. In addition, overall densities of pathological changes in the SC of 211 
each CTE case are shown in Table 2. NFT, NT, and/or DLG were present in all cases, 212 
most significant densities being present in three cases (A, D and E) while two cases 213 
(B and H) had significantly less tau pathology. AT were present in 5/8 cases at 214 
relatively low density, NP were rare and present in only one case (A), and low 215 
densities of EN were present in 7/8 cases. In addition, vacuolation was present in all 216 
cases, with a mean density of 6.24 vacuoles per field (range 0.68 – 9.62). A 217 
comparison of overall mean densities of histological features in CTE and controls is 218 
shown in Fig 4. No tau-immunoreactive pathology was observed in control cases and 219 
mean densities of NFT, NT, DLG, and AT were not significantly different to zero. In 220 
addition, there were no significant differences in density of EN (t = 0.60, P > 0.05), 221 
vacuoles (t = 0.84, P > 0.05), or frequency of contacts with blood vessels (t = 0.55, P 222 
> 0.05) in CTE and controls. However, neuronal densities were significantly greater 223 
in the SC of control than CTE cases (t = 3.76, P < 0.01). 224 
 225 
The distribution of the histological features across the laminae of the SC in each CTE 226 
case is shown in Table 3. First, in 4/8 cases, the density of NFT was significantly 227 
greater in intermediate and lower laminae, in 1/8 cases in upper laminae, and in 3/8 228 
cases there were no significant changes in density across the SC. Second, in 3/5 and 229 
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5/7 cases respectively, NT and GR were predominantly located in intermediate and/or 230 
lower laminae. Third, in 2/2 cases and in 5/7 cases respectively, AT and EN exhibited 231 
no change in density across the SC. Fourth, in all cases, the densities of neurons were 232 
greatest in upper laminae, often declining significantly across the SC. Fifth, vacuoles 233 
were present with greater density in upper or upper and intermediate laminae in 7/8 234 
cases. Sixth, changes in frequency of contacts with visible blood vessels were highly 235 
variable: in 3/8 cases there was no significant change across the SC, in 1/8 the vessels 236 
were most abundant in the intermediate laminae, a bimodal distribution was present in 237 
3/8 cases, and in one case each, blood vessels were predominantly distributed in upper 238 
or intermediate laminae.  239 
 240 
A comparison of the distribution of neurons across the SC in a typical control and 241 
CTE case is shown in Fig 5. The density of neurons in the control fluctuates across 242 
the SC, reflecting the alternating cell-rich and fiber-rich laminae, while the CTE case 243 
had significantly reduced numbers most marked in intermediate and lower laminae.  244 
 245 
Spatial correlations among the densities of histological features are shown in Table 4. 246 
In five and four cases respectively, there were positive correlations between the NFT 247 
and NT and between NFT and GR consistent with the presence of these pathologies in 248 
the same laminae. In three cases, there was a positive correlation between the 249 
densities of GR and surviving neurons and in three cases between surviving neurons 250 
and vacuoles. Spatial correlation between the tau-immunoreactive pathology (NT) and 251 
the frequency of contacts with blood vessel profiles were present in only one case. 252 
 253 
Discussion 254 
 11 
 255 
Tau-immunoreactive pathology, mainly NFT, NT, and GR was present in the SC of 256 
all eight CTE cases studied, but with considerable variation among cases, overall 257 
densities not being significantly different from zero. However, three cases had 258 
significant densities of tau pathology, a further three cases had intermediate densities, 259 
while the remaining two cases had relatively low densities, desnity being unrelated to 260 
age or duration of career. EN and vacuoles were present in CTE but not at densities 261 
significantly different from controls. In addition, considerable differences in neuronal 262 
density were evident among CTE cases, but all cases had lower overall densities than 263 
the average of the controls. Hence, neuronal loss in the SC is present in all cases 264 
while a significant degree of tau pathology was also present in a proportion of cases 265 
suggesting the SC as a potential vulnerable site of CTE pathology. 266 
 267 
Positive correlations were present among the densities of NFT, NT, and DLG, most 268 
notably between the NFT and NT/DLG suggesting a close spatial relationship 269 
between pathologies in the SC. This result supports the hypothesis that NFT, NT, and 270 
DLG could result from the degeneration of the same neurons, NFT aggregating in cell 271 
bodies and NT and DLG representing degeneration of adjacent neurites and synapses 272 
respectively.39 In addition, the correlation between the density of DLG and TN in 273 
some cases supports the hypothesis that DLG could represent synaptic degeneration 274 
within the SC. The densities of the pathological changes across the SC were rarely 275 
correlated with the frequency of contacts with visible blood vessel profiles. This 276 
finding is consistent with previous observations showing that prominent perivascular 277 
fistribution of tau pathology in CTE is limited to cortical structures and not 278 
characteristic of midbrain or other brainstem regions.5,9 Hence, the spread of tau 279 
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pathology among midbrain regions may be explained by the anatomical connections 280 
of the SC.40  281 
 282 
Comparison of the changes in density of surviving neurons across the SC in CTE and 283 
control cases suggests significant neuron loss especially in intermediate and lower 284 
laminae in CTE. The superficial laminae of the SC receive projections mainly from 285 
the retina, cortical visual areas, pretectum, and the parabigeminal nucleus, the retinal 286 
input in particular enervating the entire superficial zone (Fig 6).41 By contrast, the 287 
deeper layers also receive input from diverse sensory/motor areas, e.g., most cortical 288 
regions project to these laminae, and they also receive input from the substantia nigra, 289 
areas of the basal ganglia, spinal trigeminal nucleus, hypothalamus, zona incerta, 290 
thalamus, and inferior colliculus, some of which may also be affected in CTE. 291 
Pathological changes in the upper laminae could influence sensory analysis by the SC. 292 
By contrast, the deeper laminae send projections to many regions including the 293 
pulvinar and lateral intermediate thalamic nucleus which, in turn, send projections to 294 
cortical areas which control eye movement. In addition, the superficial laminae send 295 
projections to the pretectal nuclei, the lateral geniculate nucleus, and the 296 
parabigeminal nucleus. Projections from the deep nuclei are extensive with 297 
descending projections to brain stem and spinal cord and ascending projections to 298 
sensory/motor cortex involved in generating eye movements.41 299 
 300 
In the majority of CTE cases, tau pathology and neuronal loss in the SC were more 301 
prominent in intermediate and lower laminae rather than the superficial laminae, and 302 
therefore, these changes could affect the process of directing eye movement via the 303 
oculomotor nucleus. These results contrast with those of Petras et al42 in which rats 304 
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exposed to the effects of blast overpressure resulted in axonal degeneration in the SC 305 
principally affecting the superficial laminae II and III. However, none of our CTE 306 
cases examined had been exposed to blast damage and it is possible that laminar 307 
damage to the SC may be dependent on the type of brain injury. These findings 308 
suggest that eye movement abnormalities may be present in subjects with CTE and 309 
supports the suggestion that eye-tracking methodology might be useful as a diagnostic 310 
aid.43,44 311 
 312 
In conclusion, the present study suggests neuronal loss in the SC is a consistent 313 
feature of CTE in addition to significant tau-immunoreactive pathological change in a 314 
proportion of cases. The distribution of the pathology together with that of surviving 315 
neurons across the SC, when compared with controls, suggests that anatomical 316 
connections involving the intermediate and lower laminae could be compromised in 317 
CTE. Hence, eye movement dysfunction is a possible clinical symptom associated 318 
with potential CTE cases. Future studies of concussion in athletes would benefit if 319 
athletes who agree to donate their brains on death would complete a comprehensive 320 
eye and binocular vision examination and pass those findings on to the appropriate 321 
neuropathology center. 322 
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Table 1. Demographic features, frequency of traumatic incidents, and sporting career 517 
length of the eight chronic traumatic encephalopathy cases studied. 518 
_____________________________________________________________________519 
______ 520 
Case Onset  Duration  Death  Trauma Career 521 
 Severity 522 
 (yrs)  (yrs)  (yrs)*    length (yrs) 523 
 score 524 
_____________________________________________________________________525 
______ 526 
CTE  527 
A 65  10  75  10/2  18      4 528 
B 66  4  70  10/1  11  4 529 
C 55  6  60  1/1  26  3 530 
D 56  10  65  -  19  3 531 
E 67  15  80  F  12  4 532 
F 38  40  80  -  18  3 533 
G 55  11  65  50/1  17  3 534 
H 45  26  70  F  20  4 535 
Control 536 
A -  -  64  -  -  - 537 
B -  -  65  -  -  - 538 
C -  -  72  -  -  - 539 
D -  -  80  -  -  - 540 
E -  -  83  -  -  - 541 
F -  -  80  -  -  - 542 
_____________________________________________________________________543 
______In column 5 of CTE cases: first figure is frequency of reported traumatic 544 
episodes, second figure, episodes resulting in loss of consciousness. Abbreviations: F 545 
= frequent, (-) = data not available, * Age of CTE cases rounded to nearest 5-year age 546 
interval to protect subject identities). 547 
548 
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 Table 2. Mean densities (50 x 250m sample field) of histological features in the 549 
superior colliculus of eight cases of chronic traumatic encephalopathy.  550 
 551 
     Histological feature 552 
_____________________________________________________________________ 553 
Case  NFT NT DLG AT EN N V NP BV 554 
_____________________________________________________________________ 555 
 556 
A  1.18 10.50 22.61 0.39 0.16 11.06 5.24 0.04 0.45  557 
B  0.21 0 0.03 0 0.15 8.85 0.68 0 0.68  558 
C  0.34 0.31 0.93 0.24 0.24 4.72 0.93 0 0.93  559 
D  3.0 0.27 9.09 0.02 0.50 8.07 2.84 0 0.61  560 
E  1.11 0.32 3.43 0.04 0.09 7.37 3.89 0 0.87  561 
F  0.30 0.08 0.22 0 0 2.05 9.62 0 0.38  562 
G  0.12 0.12 0.63 0.07 0.14 5.88 7.35 0 0.33  563 
H  0.09 0.07 0.12 0 0.30 7.0 4.16 0 0.47 564 
_____________________________________________________________________ 565 
Mean control 0 0 0 0 0.15 16.43 6.14 0 0.65 566 
SE      (0.01) (0.83) (0.66)  (0.14) 567 
_____________________________________________________________________ 568 
Data for BV are frequency of contacts of a randomly drawn line across the field with 569 
visible BV profiles. Abbreviations: NFT = Neurofibrillary tangles, NT = Neuropil 570 
threads, DLG = Dot-like grains, AT = Astrocytic tangles, EN = Enlarged neurons, N = 571 
Neurons, V = Vacuoles, NP = Neuritic plaques, BV = Blood vessels, SE = Standard 572 
error of mean   573 
574 
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Table 3. Distribution of the histological features across the superior colliculus in 575 
eight cases of chronic traumatic encephalopathy.  576 
 577 
     Histological feature 578 
_____________________________________________________________________ 579 
Case  NFT NT DLG AT EN N V NP BV 580 
__________________________________________________________________ 581 
 582 
A  I,L I,L I,L NS NS U IL L I  583 
B  NS - - - NS U U - Bi 584 
C  I,L NS NS NS NS U U - NS 585 
D  I,L I,L I,L - L U U - Bi 586 
E  NS I,L I,L - I,L U U - NS  587 
F  U - U - -  U U - NS 588 
G  NS NS L - NS U U  - Bi  589 
H  I,L - I,L - NS U U,I - U 590 
_____________________________________________________________________ 591 
The table shows the region of the SC with highest densities of a particular histological 592 
feature. Abbreviations: NFT = Neurofibrillary tangles, NT = neuropil threads, DLG = 593 
Dot-like grains, AT = Astrocytic tangles, EN = Enlarged neurons, N = neurons, V = 594 
vacuoles, BV = Blood vessels U = Upper laminae, I = Intermediate laminae, L = 595 
Lower laminae, Bi = Bimodal distribution, NS = No significant change with density 596 
across the SC, (-) = Insufficient density to determine laminar distribution 597 
  598 
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Table 4. Summary of the spatial correlations (Pearson’s ‘r’) of the histological 600 
features across the superior colliculus in eight cases of chronic traumatic 601 
encephalopathy.       602 
Histological features  603 
_____________________________________________________________________ 604 
NFT NT DLG AT EN N V BV 605 
_____________________________________________________________________ 606 
NFT  - 5,0 4,0 0 2,0 2,0 1,1 0 607 
 608 
NT   - 2,0 0 0 1,0 0,1 1,0 609 
 610 
DLG    - 0 0 3,0 1,2 0 611 
 612 
AT     - 0 0 0 0 613 
 614 
EN      - 0 0 0 615 
 616 
N       - 3,1 0,1 617 
 618 
V        - 1,0  619 
 620 
BV         - 621 
_____________________________________________________________________ 622 
First and second figures are number of cases with positive and negative correlations 623 
respectively. Abbreviations: NFT = Neurofibrillary tangles, NT = Neuropil threads, 624 
DLG = Dot-like grains, AT = Astrocytic tangles, EN = Enlarged neurons, N = 625 
Neurons, V = Vacuoles, BV = Blood vessels   626 
627 
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Legends to figures 628 
 629 
Fig 1. Section through the superior colliculus (SC) showing the approximate location 630 
of the seven laminae (I – VII); PAG = Periaqueductal gray; luxol fast blue in 631 
combination with hematoxylin and eosin (LHE), bar = 1 mm. 632 
 633 
634 
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Fig 2. Pathology in the superior colliculus (SC) of a case of chronic traumatic 635 
encephalopathy (CTE) showing tau-immunoreactive pathology predominantly in 636 
lower laminae. Arrow head = neurofibrillary tangle (NFT), Arrow = Grain, Star = 637 
dystrophic neurite (DN); Phosphorylated tau (AT8) immunohistochemistry, bar = 20 638 
m). 639 
 640 
641 
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Fig 3. The overall abundance of tau-immunoreactive pathology (brown 642 
immunostaining) in the superior colliculus (SC) of each case (cases A to E) of chronic 643 
traumatic encephalopathy (CTE) and in a control case; Phosphorylated tau (AT8) 644 
immunohistochemistry, bars = 300 m). 645 
 646 
647 
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Fig 4. Mean densities of histological features (NFT = Neurofibrillary tangles, NT = 648 
neuropil threads, GR = Grains, AT = Astrocytic tangles, EN = Enlarged neurons, N = 649 
Neurons, V = Vacuoles, BV = Blood vessels) in the superior colliculus (SC) of 650 
control and cases of chronic traumatic encephalopathy (CTE). Comparison of CTE 651 
and control cases: NFT t = 2.28 (P > 0.05), NT t = 1.13, P > 0.05, DLG t = 1.66, P > 652 
0.05, AT t = 1.87, P > 0.05), EN t = 0.54 (P > 0.05), vacuoles t = 0.92 (P > 0.05), 653 
blood vessel contacts t = 0.35 (P > 0.05), Neurons t = 3.82 (P < 0.01). 654 
655 
 30 
  656 
 657 
Fig 5. The distribution of the surviving neurons across the superior colliculus (SC) in 658 
a control brain and a case of chronic traumatic encephalopathy (CTE) (Case G). In 659 
both cases, variation in density of neurons with distance across the SC was fitted by a 660 
third-order (cubic) polynomial. 661 
662 
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 663 
 664 
Fig 6. Input and output connections of the various laminae of the superior colliculus 665 
(SC) (LGN = Lateral geniculate nucleus). Based on Brodal41 666 
 667 
 668 
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